GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arovella Therapeutics Ltd (FRA:E4NA) » Definitions » Price-to-Tangible-Book

Arovella Therapeutics (FRA:E4NA) Price-to-Tangible-Book : 33.25 (As of May. 26, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Arovella Therapeutics Price-to-Tangible-Book?

As of today (2024-05-26), Arovella Therapeutics's share price is €0.0665. Arovella Therapeutics's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was €0.00. Hence, Arovella Therapeutics's Price to Tangible Book Ratio of today is 33.25.

The historical rank and industry rank for Arovella Therapeutics's Price-to-Tangible-Book or its related term are showing as below:

FRA:E4NA' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.73   Med: 8.69   Max: 99.09
Current: 40

During the past 13 years, Arovella Therapeutics's highest Price to Tangible Book Ratio was 99.09. The lowest was 2.73. And the median was 8.69.

FRA:E4NA's Price-to-Tangible-Book is not ranked
in the Biotechnology industry.
Industry Median: 2.79 vs FRA:E4NA: 40.00

A closely related ratio is called PB Ratio. As of today, Arovella Therapeutics's share price is €0.0665. Arovella Therapeutics's Book Value per Sharefor the quarter that ended in Dec. 2023 was €0.00. Hence, Arovella Therapeutics's P/B Ratio of today is 33.25.


Arovella Therapeutics Price-to-Tangible-Book Historical Data

The historical data trend for Arovella Therapeutics's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arovella Therapeutics Price-to-Tangible-Book Chart

Arovella Therapeutics Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.15 - 3.50 1.90 8.67

Arovella Therapeutics Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.83 1.90 3.33 8.67 33.75

Competitive Comparison of Arovella Therapeutics's Price-to-Tangible-Book

For the Biotechnology subindustry, Arovella Therapeutics's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arovella Therapeutics's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arovella Therapeutics's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Arovella Therapeutics's Price-to-Tangible-Book falls into.



Arovella Therapeutics Price-to-Tangible-Book Calculation

Arovella Therapeutics's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2023 )
=0.0665/0.002
=33.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Arovella Therapeutics Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Arovella Therapeutics's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Arovella Therapeutics (FRA:E4NA) Business Description

Traded in Other Exchanges
Address
62 Lygon Street, Level 3, Carlton, WA, AUS, 3053
Arovella Therapeutics Ltd is a biotechnology company focused on developing therapies to treat human diseases. Its two focus areas are oncology and conditions that impact the central nervous system. The company's principal activity is the pharmaceutical development of its invariant Natural Killer T (iNKT) cell platform for the treatment of cancer.

Arovella Therapeutics (FRA:E4NA) Headlines

No Headlines